APC Anti-Human TCR γ/δ Antibody[B1]

Introducing the APC Anti-Human TCR γ/δ Antibody [B1], a cutting-edge product designed to revolutionize the field of immunology. This antibody, available in a convenient size of 20 tests, offers unparalleled specificity and sensitivity, making it an indispensable tool for researchers and clinicians alike.

Crafted with utmost precision, this antibody targets the T-cell receptor (TCR) γ/δ, a crucial component of the immune system. By selectively binding to this receptor, our antibody enables the identification and analysis of γ/δ T-cells with remarkable accuracy.

The APC Anti-Human TCR γ/δ Antibody [B1] boasts exceptional performance characteristics, ensuring reliable and reproducible results. Its advanced formulation guarantees minimal background noise, allowing for precise detection and quantification of γ/δ T-cells in various biological samples.

This antibody is meticulously manufactured using state-of-the-art techniques, ensuring exceptional quality and consistency. Rigorous quality control measures are implemented throughout the production process, guaranteeing optimal performance and reliability.

The APC Anti-Human TCR γ/δ Antibody [B1] is compatible with a wide range of applications, including flow cytometry, immunohistochemistry, and immunofluorescence. Its versatility allows for seamless integration into diverse experimental setups, facilitating comprehensive investigations into the role of γ/δ T-cells in various disease states.

Furthermore, this antibody is designed to provide exceptional convenience and ease of use. Its user-friendly format simplifies experimental procedures, saving valuable time and resources. With the APC Anti-Human TCR γ/δ Antibody [B1], researchers can focus on their scientific endeavors without the burden of complex protocols.

In summary, the APC Anti-Human TCR γ/δ Antibody [B1] is a game-changing product that empowers researchers and clinicians to unravel the mysteries of the immune system. With its exceptional specificity, sensitivity, and versatility, this antibody is poised to redefine the boundaries of immunological research. Invest in the future of immunology with the APC Anti-Human TCR γ/δ Antibody [B1] and unlock new insights into the intricate workings of the human immune system.